A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
Clinical trial NCT04418297 · TERMINATED
Trial details
- NCT number
- NCT04418297
- Sponsor
- Celltrion
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2022-11-22
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.